Paper42918924PubMed
Fractional CO₂ laser combined with intradermal and topical platelet-rich plasma for hypertrophic scars: a randomized controlled trial.
Sun J and 4 others. Lasers Med Sci, 2026.
Cite this record
ConductScience Library. Fractional CO₂ laser combined with intradermal and topical platelet-rich plasma for hypertrophic scars: a randomized controlled trial. Papers, record 42918924. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42918924
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Fractional CO₂ laser combined with intradermal and topical platelet-rich plasma for hypertrophic scars: a randomized controlled trial.
- Journal
- Lasers Med Sci
- Year
- 2026
- Publication types
- Journal Article, Randomized Controlled Trial
- Revised in PubMed
- 2026-11-05
Source PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Platelet-Rich Plasma | Major topic |
| Cicatrix, Hypertrophic | Major topic |
| Lasers, Gas | Major topic |
| Low-Level Light Therapy | Major topic |
| Humans | |
| Female | |
| Male | |
| Prospective Studies | |
| Adult | |
| Combined Modality Therapy | |
| Injections, Intradermal | |
| Treatment Outcome | |
| Patient Satisfaction | |
| Middle Aged | |
| Young Adult | |
| Single-Blind Method | |
| Adolescent |
Source PubMed
References33
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 42014607 | Platelet-rich plasma and ablative fractional carbon dioxide laser therapy for chronic scar management: a systematic review. | Lasers Med Sci | 2026 | https://conductscience.org/library/papers/42014607 | PubMed |
| 2 | 34487566 | The efficacy and safety of low-energy carbon dioxide fractional laser use in the treatment of early-stage pediatric hypertrophic scars: A prospective, randomized, split-scar study. | Lasers Surg Med | 2022 | https://conductscience.org/library/papers/34487566 | PubMed |
| 3 | 8604867 | Clinical significance of reported changes in pain severity. | Ann Emerg Med | 1996 | https://conductscience.org/library/papers/8604867 | PubMed |
| 4 | 29781178 | The effects of platelet-rich plasma on hypertrophic scars fibroblasts. | Int Wound J | 2018 | https://conductscience.org/library/papers/29781178 | PubMed |
| 5 | 41716608 | Effects of New Cellular Treatment Factor and Human Exosome Injection on Intact Skin Regeneration in a Randomized In Vivo Study. | Plast Reconstr Surg Glob Open | 2026 | https://conductscience.org/library/papers/41716608 | PubMed |
| 6 | 26400875 | Fallacies of last observation carried forward analyses. | Clin Trials | 2016 | https://conductscience.org/library/papers/26400875 | PubMed |
| 7 | 36899815 | An Updated Review of Hypertrophic Scarring. | Cells | 2023 | https://conductscience.org/library/papers/36899815 | PubMed |
| 8 | 37979279 | Combining scar-modulating agents for the treatment of hypertrophic scars and keloids: A systematic review. | J Plast Reconstr Aesthet Surg | 2024 | https://conductscience.org/library/papers/37979279 | PubMed |
| 9 | 39780524 | Fractional CO2 Laser to Treat Surgical Scars: A System Review and Meta-Analysis on Optimal Timing. | J Cosmet Dermatol | 2025 | https://conductscience.org/library/papers/39780524 | PubMed |
| 10 | 42376274 | Plant Exosome Injection with or without Low Level Laser Therapy Promotes Skin Wound Healing: An Experimental Study. | Plast Reconstr Surg Glob Open | 2026 | https://conductscience.org/library/papers/42376274 | PubMed |
| 11 | 41277469 | Regenerative Potential of Various Plant-Derived Exosome Injections in Laser-Induced Skin Wound Healing in a Rabbit Model. | J Cosmet Dermatol | 2025 | https://conductscience.org/library/papers/41277469 | PubMed |
| 12 | 38205425 | Post-inflammatory hyperpigmentation after carbon dioxide laser: review of prevention and risk factors. | Dermatol Reports | 2023 | https://conductscience.org/library/papers/38205425 | PubMed |
| 13 | 39358919 | Evaluation of the efficacy, safety and satisfaction rates of platelet-rich plasma, non-cross-linked hyaluronic acid and the combination of platelet-rich plasma and non-cross-linked hyaluronic acid in patients with burn scars treated with fractional CO2 laser: A randomized controlled clinical trial. | Int Wound J | 2024 | https://conductscience.org/library/papers/39358919 | PubMed |
| 14 | 15253184 | The patient and observer scar assessment scale: a reliable and feasible tool for scar evaluation. | Plast Reconstr Surg | 2004 | https://conductscience.org/library/papers/15253184 | PubMed |
| 15 | 37677095 | Platelet rich plasma use for treatment of acne scars: an overview of systematic reviews. | Blood Transfus | 2024 | https://conductscience.org/library/papers/37677095 | PubMed |
| 16 | 36268335 | Standardization and validation of a conventional high yield platelet-rich plasma preparation protocol. | Ann Med Surg (Lond) | 2022 | https://conductscience.org/library/papers/36268335 | PubMed |
| 17 | 3377516 | The validity and practicality of sun-reactive skin types I through VI. | Arch Dermatol | 1988 | https://conductscience.org/library/papers/3377516 | PubMed |
| 18 | 38594186 | Ultrasound measurement of traumatic scar and skin thickness: a scoping review of evidence across the translational pipeline of research-to-practice. | BMJ Open | 2024 | https://conductscience.org/library/papers/38594186 | PubMed |
| 19 | 38275368 | Platelet-Rich Plasma (PRP) in Dermatology: Cellular and Molecular Mechanisms of Action. | Biomedicines | 2023 | https://conductscience.org/library/papers/38275368 | PubMed |
| 20 | 36683276 | Characterization of an ablative fractional CO2 laser-induced wound-healing model based on in vitro 3D reconstructed skin. | J Cosmet Dermatol | 2023 | https://conductscience.org/library/papers/36683276 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42918924
GET https://conductscience.org/api/papers/v1/42918924/references?page=2